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a b s t r a c t
Our primary objective was to determine the efﬁcacy of a siderophore receptor and porin proteins-based
vaccine (VAC) and a Lactobacillus acidophilus-based direct-fed microbial (DFM) against fecal shedding
of Escherichia coli O157:H7 in commercial feedlot cattle fed a corn grain-based diet with 25% distiller’s
grains. Cattle projected to be on a ﬁnishing diet during the summer were randomly allocated into 40
study pens within ten blocks based on allocation dates. Blocks were complete; each of the four pens
within a block was randomly assigned one treatment: control, VAC, DFM, or VAC+DFM. The DFM was
fed (106 CFU/animal/day of Lactobacillus) throughout the study periods (84–88 days) and cattlewere vac-
cinated at enrollment and again three weeks later. Fresh fecal samples (30/pen) from pen ﬂoors were
collectedweekly for four consecutiveweeks (studydays 52–77). Twoconcurrent cultureprocedureswere
used to enable estimates of E. coli O157:H7 shedding prevalence and prevalence of high shedders. From
4800 total samples, 1522 (31.7%) were positive for E. coli O157:H7 and 169 (3.5%) were considered high
shedders. Pen-level linear mixed models were used for data analyses. There were no signiﬁcant inter-
actions among treatments and time of sampling. However, vaccinated pens had lower (P<0.01) overall
prevalenceofE. coliO157:H7 (model-adjustedmean±SEM=17.4±3.95%) and lower (P<0.01)prevalence
of high shedders (0.95±0.26%) than unvaccinated pens (37.0±6.32% and 4.19±0.81%, respectively).
There was no evidence of a DFM effect on either measure of E. coli O157:H7 shedding. Results indicate
that a two-dose regimen of the vaccine signiﬁcantly reduces fecal prevalence of E. coli O157:H7 (vac-
cine efﬁcacy of 53.0%) and prevalence of E. coli O157:H7 high shedders (vaccine efﬁcacy of 77.3%) in
commercial feedlot cattle reared in the summer on a ﬁnishing diet with 25% distiller’s grains.. Introduction
Escherichia coliO157:H7 is an important cause of food-borne ill-
ess [1]. In addition to public health concerns, the economic impact
f E. coli O157:H7 has been severe [2]. Pre-harvest interventions
hat reduce fecal sheddingof thesebacteria in cattlehave thepoten-
ial to enhance food safety and reduce economic impacts of E. coli
157:H7. It has been proposed that beef processors extend their
Abbreviations: ADG, average (mean) daily weight gain; DFM, direct fed micro-
ial; DG, distiller’s grains; F:G, ratio of feed weight to gained weight of cattle; IMS,
mmunomagnetic separation; SRP, siderophore receptor and porin proteins-based
accine; VAC, vaccinated group.
∗ Corresponding author at: #307 Coles Hall, Kansas State University, Manhattan,
S 66506, USA. Tel.: +1 785 532 4801.
E-mail address: drenter@vet.k-state.edu (D.G. Renter).
264-410X © 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.
ttp://dx.doi.org/10.1016/j.vaccine.2012.05.080© 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.
food safety plans to the pre-harvest phase by purchasing cattle
from producers who implement E. coli O157:H7 control programs
[3]. However, most pre-harvest interventions have not been vali-
dated for the diverse production settings in the beef industry [3–5].
Both prevalence and concentration of E. coliO157:H7 in cattle feces
are associated with beef contamination; occasionally cattle shed
E. coli O157:H7 at high concentrations (e.g., >104 CFU/g of feces;
hereafter “high shedders”) [6–8]. Although few factors associated
with shedding have been consistently observed, cattle shed more
E. coli O157:H7 in summer than winter months [4,9,10]. Dietary
components also inﬂuence fecal shedding [4,9]. For instance, diets
containing distillers grains (DG), a co-product of the ethanol indus-
try, can increase E. coli O157:H7 fecal shedding [9,11,12]. Since
efﬁcacy of pre-harvest interventions ismost important during peri-
ods of high fecal shedding [13], data from studies of cattle fed
DG-supplemented diets in the summer months are important.
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Two interventions that are commercially available in the United
tates and have demonstrated efﬁcacy for reducing E. coli O157:H7
hedding in cattle are a siderophore receptor and porin (SRP)
roteins-based vaccine and a Lactobacillus acidophilus-based direct-
ed microbial (DFM) [5,14]. This DFM includes a strain of L.
cidophilus (NP51) shown to have inhibitory effects on E. coli
157:H7 [10]. The vaccine uses SRP proteins as antigens so immu-
ized animals produce anti-SRP antibodies that bind to outer
embrane proteins of bacterial cells and block iron transport [15].
lthough literature indicates potential beneﬁts of these products,
here is a need for additional data on efﬁcacy in commercial set-
ings [5,14]. Further, there are no data on concurrent use of these
nterventions. Therefore, our primary objective was  to determine
he efﬁcacy of intervention programs including the SRP vaccine, the
FM, or both products against fecal shedding of E. coli O157:H7 in
ens of commercial feedlot cattle fed a DG-supplemented ﬁnish-
ng diet during the summer. A secondary objective was  to evaluate
mpacts of intervention programs on cattle health and performance
utcomes as compared to control cattle reared using standard prac-
ices.
. Materials and methods
A  commercial feedlot in Nebraska, USA was identiﬁed based on
riteria that included: capacity to ﬁll 40 pens with cattle on a ﬁnish-
ng diet during summer, use of a ﬁnishing diet that included ≥25%
G, ability to feed the DFM, willingness to vaccinate cattle accord-
ng to protocol, and ability to perform research. Individual cattle
ere eligible for inclusion if projected to be on a ﬁnishing diet dur-
ng summer; with this feedlot’s management system, cattle had to
e enrolled approximately 100 days prior to harvest of the ﬁrst sub-
et. Following a brief transition period, cattle were fed a ﬁnishing
iet which included (dry matter basis): 46.4% high moisture corn,
5.0% wet DG, 17.0% corn gluten, 7.1% silage, 2.5% steep, and 2.0%
icro/minerals mix  (including 280 mg  of monensin/animal/day
nd 90 mg  of tylosin/animal/day (Elanco Animal Health, Greenﬁeld,
N, USA)). The feedlot’s standard operating procedures were fol-
owed for cattle care and management; sprinklers were used as
eeded to reduce heat stress risks. Kansas State University (KSU)
nstitutional Animal Care and Use Committee approved the study
#2723).
The study was designed as a randomized complete block with
 2 × 2 factorial treatment structure. A priori sample size esti-
ates were generated by data simulation and power calculations;
ssumptions included: 40% mean control group prevalence of
. coli O157:H7 [16], 25% mean prevalence in pens receiving an
ntervention, and no interaction among interventions. Forty pens
10/treatment) and 120 samples (30/week for four weeks) per
en were considered sufﬁcient for 80% statistical power to detect
xpected treatment differences with a 5% Type 1 error. Individual
attle were randomly allocated to 40 pens grouped in 10 blocks
deﬁned based on allocation dates; March 31 through May  14,
011). Within block, one pen each was randomly allocated to one
reatment: control, administered vaccine (VAC), fed DFM (DFM),
r both VAC and DFM (VAC + DFM). Cattle in VAC and VAC + DFM
roups were administered a 2 mL  dose of the vaccine subcuta-
eously (SC, 1½ in. needle) in the left lower neck on study day 0
nd again three weeks later (E. coli SRP® vaccine, Pﬁzer Animal
ealth, New York, NY, USA; lot # 840-0006, expiration August 19,
011). Cattle allocated to DFM or control groups never received
 placebo and were not re-handled three weeks following enroll-
ent. The DFM, labeled for 106 CFU/animal/day of L. acidophilus
nd 109 CFU/animal/day of Propionibacterium freudenreichii, was
ed throughout the study periods (Bovamine®, Nutrition Physiology
orp., Guymon, OK, USA). On study day 0, all cattle received a herpes (2012) 6210– 6215 6211
virus  vaccine (Pyramid IBR, Boehringer Ingelheim Vetmedica Inc.,
St. Joseph, MO,  USA; 2 mL,  SC) and a growth promoting implant
(Synovex Choice, Pﬁzer Animal Health, New York, NY, USA; SC in
the left ear).
The  feedlot’s computer system randomly allocated animals to
treatment groups as they were handled on study day 0. For each
block, four contiguous pens within the feedlot were identiﬁed and
pen locations for treatment groups within blocks were then ran-
domly allocated using the computer’s randomization algorithm.
The primary study outcome was  within-pen E. coli O157:H7 preva-
lence, whereas within-pen prevalence of high shedding animals
was considered a secondary outcome. Thus, each sample was clas-
siﬁed twice (independently) as positive or negative to: (1) a culture
procedure including immunomagnetic bead separation (IMS) to
assess fecal shedding, and (2) a direct plating culture procedure
to assess high shedding. Laboratory personnel were blinded to
treatment: samples were tracked only by sequential numbers.
Cumulative (study period) risks of cattle mortality and culling, and
cattle performance measures also were considered secondary out-
comes and were collected by feedlot staff blinded to treatment
group; personnel administering treatments did not collect health
or performance data. Average (mean) daily weight gain (ADG) and
feed conversions (F:G; ratio of feed weight to gained weight of
cattle) were calculated as:
ADG = Total weight gain of cattle (as deﬁned below)
Total cattle days
F :  G = Total dry matter weight of feed
Total weight gain of cattle (as deﬁned below)
where  total weight gain of cattle equals out-weight of cattle ﬁn-
ishing the trial plus out-weight of cattle culled plus out-weight of
dead cattle minus total enrollment weight of cattle.
Feedlot personnel performed daily health monitoring following
standardized procedures. Animals were weighed individually at the
beginning and end of the study. Fresh fecal samples (30/pen) from
animals observed defecating were collected from separate pats in
multiple areas throughout the pen. Care was  taken to avoid ground
contamination. Pens were sampled weekly for four consecutive
weeks prior to study end-dates for each block. Samples (approx-
imately 30 g) were placed in sterile bags, stored in coolers, and
transported to KSU for refrigeration (4 ◦C) until the following morn-
ing. Samples were cultured for E. coli O157:H7 using IMS  and direct
plating methods previously described [7,8]. Conﬁrmation included
a multiplex PCR for identifying the rfbE (O157), eae (intimin), stx1
(Shiga toxin 1), stx2 (Shiga toxin 2), hlyA (hemolysin), and ﬂiC (H7)
genes [17].
Pen-level general and generalized linear mixed models (LMM
and GLMM,  respectively) were used to assess potential treatment
effects. For response variables recorded as pen-level proportions,
data were ﬁt using a GLMM with a binomial distribution and a
logit link. Prevalence outcomes were the proportion of samples
positive of the total samples collected within the pen at each sam-
pling. Mortality and culling risks were proportions based on the
number of animals that died or were culled, respectively, dur-
ing the study period out of the total number of animals enrolled
within the pen. Data on ADG and F:G were modeled using LMM
that assume a Gaussian distribution. For all models, random effects
were ﬁtted to recognize block as the clustering factor and pen as
the experimental unit for treatment. For E. coli data, additional
random effects were used to account for pen-speciﬁc repeated
measures over time. Independent variables included treatments
(VAC, DFM, VAC x DFM interaction), and for E. coli data, effects
of time and time-by-treatment interaction. Model diagnostics
were based on studentized residuals (LMM)  and functions of the
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(Table 2). Fig. 2 illustrates the difference in means for vacci-
nated and non-vaccinated pens (P < 0.01) and the estimated vaccine
efﬁcacy (77.3%) for reducing prevalence of E. coli O157:H7 high
shedders.
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Fig. 2. Vaccine efﬁcacy estimates and corresponding model-adjusted1 means (with
standard error bars) demonstrating the effects a siderophore receptor and porinig. 1. Descriptive data on fecal samples from feedlot cattle that tested positive fo
ampling period. Data are summarized across all pens (treatments and blocks) sam
earson 2 statistic (GLMM). P values <0.05 were considered signif-
cant. Model-adjusted means (lsmeans back transformed to original
cale) and SE were reported, and used to estimate vaccine efﬁcacy
sing standard formula [18].
. Results
Study pens were ﬁlled with 17,148 steers. Pen sizes ranged
etween 398 and 464 steers (mean = 430.0). Mean weight at
nrollment was 378.4 kg with no signiﬁcant difference among
reatment groups. Projected ﬁnishing days were re-assessed by
eedlot personnel during the study and determined to be 14 days
arlier than expected. Resulting end-dates for study blocks ranged
etween June 20 and August 3, 2011; thus, days on study ranged
etween 84 and 88 (mean = 86.6 days) across blocks. Sampling
egan approximately ﬁve weeks prior to projected study-end for
ach block, resulting in samples collected (for four consecutive
eeks) between study days 52–56 (week one), 59–63 (week two),
6–70 (week three), and 73–77 (week four).
From 4800 total samples, 1522 (31.7%) were positive for E. coli
157:H7 and 169 (3.5%) were considered high shedders; percent-
ges by week of sampling are provided in Fig. 1. Isolates considered
. coli O157:H7 were positive for the rfbE (100%), eae (99.8%),
tx1 (66.2%), stx2 (99.5%), hlyA (99.7%), and ﬂiC (99.8%) genes.
scherichia coli O157:H7 were isolated at least once from all pens
100%) and 34 pens (85%) had at least one high shedder. Within
ens, unadjusted cumulative prevalence of shedding (across sam-
ling times) ranged between 1.7% and 66.7% and high shedder
revalence ranged between 0% and 12.5%.
Analysis of within-pen prevalence of E. coli O157:H7 shed-
ing data indicated no signiﬁcant two- or three-way interactions
mong treatments and time of sampling. There also was  no sig-
iﬁcant main effect of DFM (Table 1). However, a main effect of
AC was apparent, such that VAC decreased prevalence of fecal
hedding (Table 2). Fig. 2 illustrates estimated efﬁcacy (53.0%) of
accination for reducing fecal prevalence of E. coli O157:H7 and
eans for the contrast between vaccinated and non-vaccinated
ens (P < 0.01). A main effect of sampling time on fecal shedding
as also apparent (P = 0.02), whereby mean prevalence on sam-
ling week two differed from prevalence on week four; no otherli O157:H7 shedding and E. coli O157:H7 high shedding for each week during the
or each week.
week-to-week  differences were detected. Means (SEM) were 24.6%
(5.07), 20.7% (4.53), 27.2% (5.39) and 32.4% (5.92) for sampling
weeks one through four, respectively.
Regarding high shedder prevalence, results indicated no signif-
icant two- or three-way interactions among treatments and time
of sampling, and no signiﬁcant main effects of DFM (Table 1) or
sampling week. However, a signiﬁcant effect of VAC was  identiﬁed,
whereby vaccination decreased the prevalence of high sheddersproteins-based vaccine for controlling overall fecal prevalence of E. coli O157:H7
and  prevalence of E. coli O157:H7 high shedders in pens of commercial feedlot cattle.
A signiﬁcant vaccine effect was demonstrated for both measures of E. coli O157:H7
prevalence  (P values <0.01).1 1From generalized linear mixed models accounting for
allocation of pens within blocks and repeated measures on pens over time.
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Table  1
Model-adjusteda means, standard errors (SEM), 95% conﬁdence intervals (CI), and P values for comparisons of outcome measures between pens of feedlot cattle that were
fed  a direct-fed microbialb (DFM) containing Lactobacillus acidophilus and Propionibacterium freudenreichii (n = 20) and pens that were not fed the DFM (n = 20).
Outcome measures Fed DFM No DFM P value
Mean SEM CI Mean SEM CI
Fecal prevalence (%) 25.8 5.24 16.6–37.9 26.2 5.26 16.9–38.3 0.94
High  shedder prevalence (%) 2.16 0.49 1.36–3.42 1.87 0.47 1.12–3.11 0.59
Average  daily weight gain (kg/head/day) 1.48 0.02 1.43–1.53 1.46 0.02 1.40–1.51 0.09
Feed  to gain ratio 6.01 0.08 5.84–6.17 6.14 0.08 5.99–6.31 0.03
Mortality  risk (%) 1.14 0.11 0.93–1.40 1.08 0.11 0.87–1.34 0.70
Culling  risk (%) 0.42 0.15 0.21–0.86 0.41 0.14 0.21–0.86 0.78
a From linear mixed models accounting for allocation of pens within blocks (and repeated measures on pens over time for fecal and high shedder prevalence).
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K, USA.
Effects of treatment were apparent on both ADG and F:G, but
here were no signiﬁcant interactions between VAC and DFM. For
DG, there was no signiﬁcant DFM effect (Table 1), but the VAC
ffect was signiﬁcant (Table 2). For F:G, effects of DFM (Table 1)
nd VAC (Table 2) were both statistically signiﬁcant. There was  no
vidence of VAC and DFM interactions, main effect of DFM (Table 1),
r main effect of VAC (Table 2) on either mortality or culling risks.
.  Discussion
An important ﬁnding of this study is that two doses of the
RP® vaccine applied in a commercial feedlot reduced E. coli
157:H7 shedding by more than 50% and reduced high shedders
y more than 75%. These results from a cattle population with
elatively high levels of E. coli O157:H7 have important practi-
al implications since efﬁcacy of pre-harvest interventions is most
mportant when prevalence is high [13]. Another important ﬁnding
s that the commercial DFM (Bovamine®) had no effect on E. coli
157:H7 fecal shedding. These results also have practical signif-
cance since end-users of pre-harvest interventions may  wonder
hether these commercially available products – the SRP® vac-
ine and the Bovamine® DFM – are equally efﬁcacious. Results
lso indicate that DFM-fed cattle may  have improved performance
hereas cattle in vaccinated pens had relatively poorer perfor-
ance. Performance effects need to be further quantiﬁed since
attle performance affects beef production costs, and the adop-
ion of pre-harvest control programs will be affected by all costs
ssociated with implementation.
Study  cattle were fed a diet with 25% DG during the summer;
hus, the interventions were tested in a situation when fecal shed-
ing of E. coli O157:H7 was expected to be high. Feeding DG to cattle
an increase fecal shedding of E. coli O157:H7 approximately two  to
hreefold [9,11,12]. Seasonal effects associated with E. coli O157:H7
hedding (higher in the summer) also has been well documented;
tudy data (Fig. 1) demonstrate a well-described seasonal pattern
4,16,19]. The sample-level prevalence for high shedders (3.5%) and
able 2
odel-adjusteda means, standard errors (SEM), 95% conﬁdence intervals (CI), and P valu
accinated twice with a siderophore receptor and porin proteins-based vaccineb (n = 20) 
Outcome measures Vaccinated 
Mean SEM CI
Fecal prevalence (%) 17.4 3.95 10
High  shedder prevalence (%) 0.95 0.26 0.
Average  daily weight gain (kg/head/day) 1.45 0.02 1.
Feed  to gain ratio 6.14 0.08 5.
Mortality  risk (%) 1.14 0.11 0.
Culling  risk (%) 0.41 0.14 0.
a From linear mixed models accounting for allocation of pens within blocks (and repea
b E. coli SRP® vaccine, Pﬁzer Animal Health, New York, NY, USA.nimal/day of Propionibacterium freudenreichii), Nutrition Physiology Corp., Guymon,
overall fecal shedding (31.7%) were relatively high, but numeri-
cally similar to estimates from comparable populations. Reports on
summer-harvested cattle included prevalence estimates for high
shedders of 3.7% [7] and 3.3% [8]. Recent estimates of overall fecal
prevalence in summer-fed feedlot cattle have ranged between 37%
and 10%, but within-pen prevalence is highly variable [16,20,21].
Thus, the range in cumulative within-pen prevalence (1.7–66.7%)
reported in this current study is consistent with previous reports.
While diagnostic sensitivity and speciﬁcity of culture methods used
in this study are not perfect for identifying fecal shedding and
high shedding [22], any misclassiﬁcation would be expected to be
non-differential with respect to treatments. Further, these methods
have previously provided useful data on fecal shedding relative to
important food safety parameters such as E. coli O157:H7 carcass
and hide prevalence [7,8]. Gene proﬁles of isolates recovered in this
study are similar to those previously reported; indicating that the
E. coli O157:H7 isolates have potential for human virulence [23,24].
This is the ﬁrst published study demonstrating efﬁcacy of a
2-dose regimen of the commercially available SRP® vaccine for
reducing both the prevalence of E. coli O157:H7 shedding and high
shedding in a large-pen commercial feedlot setting. Although vac-
cine efﬁcacy has been demonstrated previously [15,25,26], key
features differ between previous studies and the study reported
here. The SRP® vaccine was ﬁrst shown to reduce fecal shedding in
young calves orally inoculated with E. coli O157:H7 [28]. Cattle that
were naturally shedding E. coli O157:H7 in a research feedlot were
used to show that 3 mL  doses of vaccine reduced fecal shedding; a
dose–response trend was  also observed [25]. In one feedlot study,
a 2-dose regimen of the vaccine reduced fecal prevalence, and in
another study, a 3-dose regimen reduced fecal concentration [26]. A
cow-calf study found no signiﬁcant vaccine effects, but cattle were
vaccinated at much different production phases [27]. In addition to
differing study designs, vaccine dosages, or study populations, this
commercial feedlot study reported here utilized very large pens
while others used smaller pens (≤70 animals/pen) [15,25,26]. A
recent systematic review indicating efﬁcacy of the SRP® vaccine
es for comparisons of outcome measures between pens of feedlot cattle that were
and pens that were not vaccinated (n = 20).
Non-vaccinated P value
 Mean SEM CI
.7–27.0 37.0 6.32 25.2–50.6 <0.01
54–1.67 4.19 0.81 2.82–6.20 <0.01
39–1.50 1.49 0.02 1.44–1.54 0.01
99–6.31 6.01 0.08 5.85–6.18 0.04
93–1.40 1.08 0.11 0.87–1.34 0.70
20–0.83 0.43 0.15 0.21–0.87 0.78
ted measures on pens over time for fecal and high shedder prevalence).
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uggested that further studies in commercial settings were needed
14].
No evidence for any DFM (Bovamine®) effect on E. coli O157:H7
ecal shedding was observed, contradicting some results of empir-
cal studies and a systematic review indicating efﬁcacy of this L.
cidophilus strain (NP51) [5,10,28–32]. Possibly larger pen sizes and
 lower dose of product in the current study compared to previous
tudies could explain seemingly contradictory results. This com-
ercial feedlot study utilized large pens while many other studies
sed much smaller (≤10 animals/pen) pens [28–32]. Further, efﬁ-
acy of this DFM for reducing E. coli O157:H7 may  be improved
t a higher dose [10,29,32]. The commercial low-dose Bovamine®
roduct (106 CFU/head/day of Lactobacillus) was utilized in the cur-
ent study because of the perception that this product can reduce
ecal shedding and also improve cattle performance. Indeed, there
re important practical implications if a pre-harvest control pro-
ram could reduce E. coli O157:H7 fecal shedding while improving
nimal performance.
A  meta-analysis demonstrated that this DFM can improve feed-
ot cattle performance [33]; reported summary effects were similar
o effects reported here. However, results indicating lower weight
ain per day and less efﬁcient feed conversion for vaccinated versus
nvaccinated pens are novel. Previous feedlot studies with this vac-
ine did not detect signiﬁcant differences in cattle performance
15]. However, in previous studies both vaccine and control groups
ere handled on re-vaccination days and controls were given a
lacebo. Further, previous studies had much smaller sample sizes
o detect differences with half as many pens (20) and much fewer
nimals overall (<1300) than the current study (40 and >17,000,
espectively). For the current study, controls were not re-handled
r given a placebo during vaccinations times because the feedlot
ould not normally do these procedures; the intent of assessing
erformance was  to evaluate the total program (not just the vac-
ine) as compared to normal production practices. Since production
osts must be considered for implementation of a vaccination
rogram, further research speciﬁcally designed for evaluating per-
ormance effects may  be warranted.
. Conclusions
We  found the overall fecal prevalence of E. coli O157:H7
nd prevalence of high shedders in this large commercial feed-
ot population were relatively high as expected for summer-fed
attle supplemented with distiller’s grains. We  conclude that
his DFM, Bovamine® (labeled for 106 CFU/head/day of Lacto-
acillus), administered alone or in combination with the SRP®
accine, does not signiﬁcantly affect fecal shedding. However,
he SRP® vaccine signiﬁcantly reduces fecal prevalence of E. coli
157:H7 and prevalence of high shedders, and therefore may  be
n effective intervention for E. coli O157:H7 control in commercial
eedlots.
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